4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Back to Agenda

Session 4: Communicating to Healthcare Professionals and Patients - Stakeholder Education

Session Chair(s)

Steffen Thirstrup, MD

Chief Medical Officer, European Medicines Agency, Netherlands

The session will explore the developments on patient leaflet, guidelines on communicating to laypeople and healthcare professionals

Speaker(s)

Representative Invited

Policy Officer, European Commission

European Commission Q&A for Patients on Biosimilar Medicines

Julie Marechal-Jamil, MSc

Director, Biosimilar Policy and Science, Medicines For Europe, Belgium

Patients’ Perception on the Information on Biosimilar Medicines

Joan Carol O'Callaghan, MPharm

Pharmaceutical Assessor, HPRA, Ireland

Choosing the Level of Language and Access to Information of Biologics and Biosimilars

Arnold Vulto, PharmD, PhD

Em. Professor of Hospital Pharmacy & Practical Therapeutics, Erasmus University Medical Center Rotterdam, Netherlands